Literature DB >> 8882961

Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas.

A Vacca1, D Ribatti, M Fanelli, F Costantino, B Nico, R Di Stefano, G Serio, F Dammacco.   

Abstract

The topography of and the area covered by tenascin, laminin and type IV collagen (all components of the subendothelial basement membrane), and the microvessel area (an index of angiogenesis), as evaluated with factor VIII, were investigated immunohistochemically in 61 B-cell non-Hodgkin's lymphomas (B-NHL) and 30 benign lymphadenopathies as controls. The three components were located in the microvessels and in a microvessel-bound stromal reticular network, the expression of tenascin being always more extended and finer than the other components. Of the lymphadenopathies, reactive and atypical lymphoid hyperplasias showed vessels and stromal network in the interfollicular zone only, whereas in Castleman's and angioimmunoblastic forms these structures were widely scattered in the tissue, and the area of the three components and that of the microvessels were significantly larger. Of the low-grade B-NHL, follicular subtypes had vessels and stromal network confined to the interfollicular inflammatory zone, but not in tumor follicles, whereas these structures were irregularly distributed throughout the small lymphocytic subtype. The levels of areas in low-grade B-NHL overlapped those of Castleman's and angioimmunoblastic lymphadenopathies. Among the intermediate-grade tumors, the follicular subtype resembled the follicular tumors, and the diffuse subtypes displayed vessels and stromal network throughout the tissue in close association with the neoplastic cells, and with significant increments of both the tenascin and the microvessel areas, but with a significant reduction of both the laminin and the type IV collagen areas. Distribution was similar in high-grade B-NHL, but tenascin and microvessel area variations, on the one hand, and those of laminin and type IV collagen areas were still more apparent than in the intermediate-grade. A high correlation was demonstrated in all groups of tissues between tenascin and microvessel area. In addition, in the diffuse intermediate-grade and high-grade B-NHL highly immature vessels were frequently detected by ultramicroscopy. The results show that tenascin expression and angiogenesis are closely related, and that both increase in function of tumor malignancy. Unlike laminin and type IV collagen, tenascin is associated with highly immature vessels in B-NHL. We suggest that tenascin expression and angiogenesis are governed by the B-NHL-associated inflammatory infiltrate, as well as by the B-NHL cells, particularly in more malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882961     DOI: 10.3109/10428199609054786

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  Tenascin expression in primary and recurrent breast carcinomas and the effect of tenascin on breast tumor cell cultures.

Authors:  A M Tokés; S Paku; S Tóth; E Paál; J Kulka; J Tóth; A Telekes
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

Review 2.  The role of angiogenesis in human non-Hodgkin lymphomas.

Authors:  Domenico Ribatti; Beatrice Nico; Girolamo Ranieri; Giorgina Specchia; Angelo Vacca
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

3.  Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas?

Authors:  D Ribatti; B Nico; A Vacca; A Marzullo; N Calvi; L Roncali; F Dammacco
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

4.  Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas.

Authors:  A Vacca; D Ribatti; L Ruco; F Giacchetta; B Nico; F Quondamatteo; R Ria; M Iurlaro; F Dammacco
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

Review 5.  Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.

Authors:  Nonkululeko N Mthembu; Zukile Mbita; Rodney Hull; Zodwa Dlamini
Journal:  HIV AIDS (Auckl)       Date:  2017-03-30

6.  Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.

Authors:  Giuseppe Gritti; Andrea Gianatti; Fiorella Petronzelli; Rita De Santis; Chiara Pavoni; Riccardo Lorenzo Rossi; Laura Cattaneo; Luigi Giusto Spagnoli; Silvia Ferrari; Andrea Rossi; Anna Maria Barbui; Alessandro Rambaldi
Journal:  Oncotarget       Date:  2018-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.